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Fecal viral concentrations of 40 patients infected with 
norovirus genogroup GII.4 correlated with diarrhea duration 
and frequency of vomiting. Higher viral concentration and 
older age were independently associated with prolonged di-
arrhea (>4 days). These ﬁ  ndings provide information on the 
pathogenesis and transmission of norovirus infections.
N
orovirus is a major cause of viral gastroenteritis world-
wide, accounting for at least 28% of all foodborne out-
breaks (1). However, its pathogenesis is poorly understood 
(2). Although the disease is usually perceived as mild and 
self-limiting (symptoms generally subside within 2–3 days 
in otherwise healthy persons) (1,2), protracted diarrhea and 
serious complications may develop in elderly or immuno-
compromised patients (2–4).
We have previously shown that patients infected with 
norovirus genogroup GII have at least 100-fold higher fecal 
viral concentrations than those infected with genogroup GI 
(5), which may help explain the former’s global predomi-
nance (6,7). However, whether fecal viral concentration 
has any association with disease manifestation is unknown. 
In this study, we postulated that a higher viral concentra-
tion is associated with more severe symptoms. We studied 
potential associations in patients infected with norovirus 
GII.4, the predominant norovirus genotype circulating in 
Hong Kong during the study period (6,7).
The Study
During a 2-year period (November 2004–November 
2006), 44 adult (>16 years of age) patients at 2 regional 
hospitals in Hong Kong Special Administrative Region 
with acute gastroenteritis were shown to be infected with 
norovirus genogroup GII.4. Clinical records were reviewed 
and baseline characteristics, clinical features, and output 
charts were studied. Cases were included for analysis if 
stool samples were collected <96 hours from symptom on-
set. Diarrhea was deﬁ  ned as having >3 loose stools per day. 
Duration of diarrhea was deﬁ  ned as the number of days (in-
clusive) between the ﬁ  rst and ﬁ  nal dates of symptoms (3).
Stool samples were collected from all patients when 
initially observed and processed immediately for RNA ex-
traction. Diagnosis of norovirus infection and its quantita-
tion were based on real-time reverse transcription–PCR as-
say of stool samples as described (5). The lower detection 
limit of the assay was 2 × 104 copies of cDNA/g stool. Phy-
logenetic studies were also performed as described (5).
Associations between clinical parameters and fecal vi-
ral cDNA concentrations were determined. Univariate as-
sociations between fecal viral concentration (log10 copies 
cDNA/g fecal specimen), baseline characteristics, and clini-
cal variables were examined by using the Mann-Whitney 
test or χ2 test as appropriate. Variables with a p value <0.1 
in univariate analyses were entered into multivariate mod-
els as covariates. Stepwise backward logistic regression was 
performed to identify independent variables associated with 
prolonged diarrhea, deﬁ  ned as >4 days of diarrhea. This cut-
off was based on the results of many observational studies 
(1–4) and was also above the median duration of diarrhea in 
this cohort. Spearman rank correlation coefﬁ  cient (ρ) was 
used to assess correlations between viral cDNA concentra-
tion and other continuous variables. A p value <0.05 was 
considered statistically signiﬁ  cant. All probabilities were 
2-tailed. Statistical analysis was performed with SPSS soft-
ware version 13.0 (SPSS Inc., Chicago, IL, USA).
Stool samples from 40 patients were analyzed. Mean 
± SD age of patients was 60.4 ± 24.3 years and 15 (37.5%) 
were males. Seventeen patients (42.5%) had pre-existing 
medical conditions, and 21 (52.5%) were hospitalized. Di-
arrhea was observed in 100%, whereas vomiting and fever 
were observed  in 64.9% and 36.8%, respectively. Median 
duration of diarrhea was 3 days (range 2–6 days). Median 
fecal cDNA concentration was 8.93 log10 copies/g stool (in-
terquartile range 8.22–10.24 log10 copies/g stool).
Fecal viral cDNA concentration was examined in re-
lation to baseline characteristics and clinical symptoms 
(Table). Higher viral concentrations were associated with 
older age (p = 0.064). Higher fecal viral concentration was 
signiﬁ  cantly associated with prolonged diarrhea >4 days 
(2.11 log10 copies/g stool; p = 0.001, by Mann-Whitney 
test) than with limited diarrhea (Figure 1). Viral concentra-
tion was positively correlated with total duration of diar-
rhea (Spearman ρ 0.47, p = 0.004) and total frequency of 
vomiting (Spearman ρ 0.34, p = 0.043) during the course of 
illness (online Appendix Figure, available from www.cdc.
gov/EID/content/13/9/1399-appG.htm). Fever developed 
more frequently in patients with prolonged diarrhea (64.3% 
vs. 21.7%; p = 0.010, by χ2 test). Mean total frequency of 
diarrhea and vomiting was 14.9 and 3.1, respectively, in in-
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patients with prolonged diarrhea and 11.8 and 1.2, respec-
tively, in those with limited diarrhea. We did not observe 
an association between mean daily output and fecal viral 
concentrations in this cohort.
To rule out possible confounding by variations in 
sample collection time, fecal viral cDNA concentration 
was also examined by sample collection day (Figure 2). In 
general, samples collected from patients with prolonged 
diarrhea had higher viral concentrations on all collection 
days. The mean day of sample collection was slightly later 
in patients with prolonged diarrhea than in those with lim-
ited symptoms (2.4 ± 1.3 days vs. 1.5 ± 1.1 days; p = 0.045, 
by t test).
Prolonged diarrhea >4 days was associated with old-
er age and pre-existing medical conditions by univariate 
analyses (p<0.05 for both variables, by χ2 test) and with fe-
cal viral concentration. Stepwise backward logistic regres-
sion analysis showed that fecal viral concentration (odds 
ratio [OR] 9.56, 95% conﬁ  dence interval [CI] 1.18–77.57 
per log10 copies; p = 0.035) and age (OR 1.15, 95% CI 
1.03–1.28) per year; p = 0.013) were 2 independent factors 
associated with prolonged diarrhea caused by norovirus 
genotype GII.4.
Conclusions
To our knowledge, this is the ﬁ  rst clinical study to 
demonstrate that fecal viral concentration correlates with 
duration of illness in norovirus gastroenteritis. It has been 
reported that severe protracted diarrhea caused by norovirus 
infection can develop in hospitalized, elderly, and immuno-
compromised patients (3,4,8). Such patients often shed vi-
rus for prolonged periods, which probably indicates active 
viral replication and slow viral clearance (4,8). In an animal 
model, norovirus was shown to infect and possibly replicate 
in enterocytes, resulting in disease (9). Results of our study 
thus provide preliminary evidence that active viral replica-
tion determines clinical disease in norovirus gastroenteritis, 
as in most other viral infections (10). These ﬁ  ndings also 
suggest that more stringent infection control measures need 
Table. Fecal viral concentrations of 40 patients infected with norovirus* 
Comparison groups (%)  Median fecal viral concentration, log10 copies cDNA/g stool (IQR)  p value 
Age, y 
 <65  (47.5)  8.48  (7.79–10.11) 
   65 (52.5)  8.97 (8.54–10.70) 
0.064
Sex 
  Male (37.5)  8.97 (7.79–10.72) 
 Female  (62.5)  8.88  (8.24–10.22) 
0.706
Pre-existing medical conditions† 
 No  (57.5)  8.95  (7.86–10.26) 
  Yes (42.5)  8.91 (8.31–10.14) 
0.520
Diarrhea duration‡ 
  Limited (62.2)  8.38 (7.89–9.45) 
 Prolonged  (37.8)  10.49  (8.84–10.94) 
0.001
Vomiting
  No (35.1)  8.71 (7.71–9.91) 
  Yes (64.9)  9.10 (8.25–10.40) 
0.215
Fever§ 
 No  (62.2)  8.77  (8.15–10.17) 
  Yes (36.8)  9.13 (8.23–10.75) 
0.380
*IQR, interquartile range. 
†Includes diabetes mellitus, chronic cardiovascular/pulmonary/hepatic diseases, and underlying malignancies. No patient had conditions associated with 
profound immunosuppression in this cohort. 
‡Limited (62.2%) is defined as a total duration of diarrhea of 1–3 d, including both hospitalized and nonhospitalized patients (followed up by the same 
hospital’s emergency departments as outpatients).Prolonged (37.8%) is defined as a total duration of diarrhea ≥4 d; all but 1 were hospitalized patients. 
§Temperature >37.5°C on >1 occasion. 
Figure 1. Box plot of median (black horizontal bars) and interquartile 
range (error bars) of fecal norovirus cDNA concentrations in patients 
with limited and prolonged diarrhea. Limited diarrhea is deﬁ  ned as 
a total duration of diarrhea of 1–3 days, and prolonged diarrhea is 
deﬁ  ned as a total duration of diarrhea ≥4 days.Viral Concentration and Norovirus Gastroenteritis
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to be implemented in patients with severe diarrhea because 
of high fecal viral concentrations (1–4,8).
This study was limited by a small sample size and fe-
cal viral concentration, which was studied only at 1 time 
point for each patient. Further research on changes in fecal 
viral concentrations and their relationships with disease se-
verity are warranted. Because no previous clinical studies 
describe temporal changes of norovirus concentration in 
relation to symptoms, we analyzed viral concentration data 
only in patients with acute diarrhea (days 0–4). Although 
our deﬁ  nition of prolonged diarrhea (>4 days, which was 
above the median in our cohort) seemed arbitrary, it is sup-
ported by the results of many observational studies, which 
show that in most patients (even elderly or hospitalized pa-
tients), acute symptoms subside within 2–3 days (1–4,8). 
Inclusion of only norovirus GII.4 infections in the analysis 
removed the possible confounder of strain variation on vi-
ral concentration (5). Whether similar correlations can be 
observed with other norovirus strains remains uncertain. 
Given that genogroup GII.4 is the predominant circulat-
ing strain in most countries with major outbreaks (6), these 
results have implications with regard to pathogenesis and 
infection control of norovirus infections.
In conclusion, these results provide preliminary evi-
dence that a high fecal viral concentration is independently 
associated with prolonged norovirus gastroenteritis. Fur-
ther studies are needed to conﬁ  rm the role of enhanced vi-
ral replication on pathogenesis and transmission of this dis-
ease. In addition, the approach of quantifying norovirus by 
real-time PCR can be used for future evaluation of antiviral 
treatment (11) and to study factors associated with delayed 
viral clearance (3).
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Figure 2. Scatter plot showing fecal norovirus cDNA concentrations 
in patients with limited and prolonged diarrhea, according to 
sampling day. Limited diarrhea is deﬁ   ned as a total duration of 
diarrhea of 1–3 days, and prolonged diarrhea is deﬁ  ned as a total 
duration of diarrhea ≥4 days.